RT Book, Section
A1 Dushenkov, Anna
A1 Jungsuwadee, Paiboon
A2 Chisholm-Burns, Marie A.
A2 Schwinghammer, Terry L.
A2 Malone, Patrick M.
A2 Kolesar, Jill M.
A2 Bookstaver, P. Brandon
A2 Lee, Kelly C.
SR Print(0)
ID 1187026130
T1 Coagulation and Platelet Disorders
T2 Pharmacotherapy Principles & Practice, 6e
YR 2022
FD 2022
PB McGraw-Hill Education
PP New York, NY
SN 9781260460278
LK ppp.mhmedical.com/content.aspx?aid=1187026130
RD 2024/10/09
AB LEARNING  OBJECTIVESUpon  completion  of  the  chapter,  the  reader  will  be  able  to:Describe  the  basics  of  the  regulation  of  hemostasis  and  thrombosis.Select  appropriate  nonpharmacological  and  pharmacological  therapy  for  a  patient  with  hemophilia  in  a  given  clinical  situation.Calculate  an  appropriate  factor-concentrate  dose  for  a  product,  given  the  percentage  correction  desired  based  on  clinical  situation.List  possible  complications  from  hemophilia-induced  bleeding  episodes.Choose  an  appropriate  treatment  strategy  for  patients  with  factor  VIII  or  IX  inhibitors.Devise  a  treatment  plan  for  a  patient  with  a  specific  variant  of  von  Willebrand  disease  (vWD).Describe  various  recessively  inherited  coagulation  disorders  (RICDs)  and  the  role  of  specific  factor  replacement  in  RICD  management.Recommend  first-and  second-line  treatment  approaches  for  immune  thrombocytopenia  (ITP).Identify  basic  clinical  features,  causes,  and  management  of  select  thrombotic  microangiopathies  (TMAs).